HRP20080467A2 - Derivati 5-beta-sapogenina i pseudosapogenina te njihova uporaba u liječenju demencije - Google Patents

Derivati 5-beta-sapogenina i pseudosapogenina te njihova uporaba u liječenju demencije

Info

Publication number
HRP20080467A2
HRP20080467A2 HR20080467A HRP20080467A HRP20080467A2 HR P20080467 A2 HRP20080467 A2 HR P20080467A2 HR 20080467 A HR20080467 A HR 20080467A HR P20080467 A HRP20080467 A HR P20080467A HR P20080467 A2 HRP20080467 A2 HR P20080467A2
Authority
HR
Croatia
Prior art keywords
treatment
derivatives
sapogenine
pseudosapogenine
dementia
Prior art date
Application number
HR20080467A
Other languages
English (en)
Croatian (hr)
Inventor
Barraclough Paul
Hanson Jim
Gunning Phil
Rees Daryl
Xia Zongqin
Original Assignee
Phytopharm Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm Plc filed Critical Phytopharm Plc
Publication of HRP20080467A2 publication Critical patent/HRP20080467A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HR20080467A 1999-09-29 2000-09-29 Derivati 5-beta-sapogenina i pseudosapogenina te njihova uporaba u liječenju demencije HRP20080467A2 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9923076.5A GB9923076D0 (en) 1999-09-29 1999-09-29 Sapogenin derivatives and their use
PCT/GB2000/003737 WO2001023406A1 (en) 1999-09-29 2000-09-29 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

Publications (1)

Publication Number Publication Date
HRP20080467A2 true HRP20080467A2 (hr) 2008-11-30

Family

ID=10861837

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20080467A HRP20080467A2 (hr) 1999-09-29 2000-09-29 Derivati 5-beta-sapogenina i pseudosapogenina te njihova uporaba u liječenju demencije
HR20020255A HRP20020255A2 (en) 1999-09-29 2000-09-29 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20020255A HRP20020255A2 (en) 1999-09-29 2000-09-29 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia

Country Status (27)

Country Link
US (2) US7138427B2 (enExample)
EP (2) EP1224205B1 (enExample)
JP (1) JP2003510332A (enExample)
KR (1) KR100771491B1 (enExample)
CN (2) CN101411712A (enExample)
AT (1) ATE325808T1 (enExample)
AU (1) AU778294C (enExample)
BR (1) BR0014381A (enExample)
CA (2) CA2385402C (enExample)
CY (1) CY1105225T1 (enExample)
CZ (1) CZ300150B6 (enExample)
DE (1) DE60027913T2 (enExample)
DK (1) DK1224205T3 (enExample)
ES (1) ES2260055T3 (enExample)
GB (1) GB9923076D0 (enExample)
HK (1) HK1045525B (enExample)
HR (2) HRP20080467A2 (enExample)
IL (2) IL148920A0 (enExample)
MX (1) MXPA02003305A (enExample)
NO (1) NO324959B1 (enExample)
NZ (1) NZ518596A (enExample)
PT (1) PT1224205E (enExample)
RU (1) RU2325396C2 (enExample)
TR (1) TR200200821T2 (enExample)
UA (1) UA82978C2 (enExample)
WO (1) WO2001023406A1 (enExample)
ZA (1) ZA200202382B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
EP1490071B1 (en) * 2002-03-27 2009-03-04 Phytopharm Plc Therapeutic uses of sapogenins
DE60326437D1 (de) * 2002-03-27 2009-04-16 Phytopharm Plc Godmanchester Therapeutische verwendung von sapogeninen
ATE424211T1 (de) * 2002-03-27 2009-03-15 Phytopharm Plc Therapeutische verwendung von sapogeninen
MXPA05004494A (es) 2002-10-28 2005-07-26 Phytopharm Plc Reduccion estereoespecifica de sapogen-3-onas.
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0409567D0 (en) 2004-04-28 2004-06-02 Phytopharm Plc Chemical compounds
GB0424528D0 (en) 2004-11-05 2004-12-08 Phytopharm Plc Chemical compounds
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
AU2010207597A1 (en) 2009-01-24 2011-08-18 Phytopharm Plc Treatment of neurotrophic factor mediated disorders
CN101768202B (zh) * 2009-02-18 2013-10-30 沈阳药科大学 知母中菝葜皂苷元及其衍生物的制备方法及其医药新用途
JP2013543482A (ja) 2010-07-20 2013-12-05 ファイトファーム ピーエルシー Ｌ−ドーパ、ドーパミン作動薬及び／又はドーパミン賦活剤により誘発される疾患の処置
CU20110244A7 (es) * 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
WO2013149580A1 (en) 2012-04-03 2013-10-10 Chiming Che Timosaponin compounds
CN102924559B (zh) * 2012-11-16 2015-10-28 沈阳药科大学 菝葜皂苷元衍生物及其制备和应用
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
CN103232520A (zh) * 2013-05-13 2013-08-07 中国药科大学 一种螺甾类化合物、其制备方法及医药用途
CN106905407B (zh) * 2015-01-27 2019-08-13 华东理工大学 知母皂苷元结构修饰的衍生物、其药物组合物及其应用
EP3368043B1 (en) * 2015-10-29 2021-12-01 Emmyon, Inc. Furostan-3-ol derivatives as skeletal muscle hypertrophic agents
CN106977581B (zh) * 2017-04-17 2021-01-01 华东理工大学 知母皂苷元结构修饰的衍生物的应用以及药物组合物

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852847A (en) 1958-03-04 1960-11-02 British Drug Houses Ltd Improvements in or relating to 6-methyl steroid compounds
US3575810A (en) 1967-07-19 1971-04-20 Takashi Matsushima Method for removal of side chain of sapogenins
BE794362A (fr) * 1972-01-22 1973-07-23 Merck Patent Gmbh Sulfates hydrosolubles de sterine
US3929769A (en) * 1972-05-19 1975-12-30 Ciba Geigy Corp Process for the manufacture of steroid epoxides
CA985172A (en) * 1972-10-06 1976-03-09 Dushan M. Dvornik Compositions and methods for reducing blood cholesterol
DE2416978A1 (de) * 1974-04-08 1975-10-09 Degussa Arzneimittel mit dem hauptsapogenin der helleborus-arten als wirkstoff
LU81256A1 (fr) * 1979-05-15 1980-12-16 Oreal Composition cosmetique capillaire notamment pour le lavage et/ou le demelage des cheveux,a base d'un extrait de plantes contenant des saponosides
IT1144136B (it) 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
GB2097672A (en) 1981-05-01 1982-11-10 Pattni Ramesh Damji Devji Process for extraction of crude sapogenins from Agave Leaves
JPS5855500A (ja) * 1981-09-25 1983-04-01 Tokiwa Yakuhin Kogyo Kk １６−デヒドロプレグネノロンの製造法
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4562250A (en) * 1982-09-13 1985-12-31 Regents Of The University Of Minnesota Steroidal glycosides produced by Yucca tissue culture
US4546097A (en) * 1983-11-04 1985-10-08 The United States Of America As Represented By The Department Of Health And Human Services Saponin-based polyether polyols, pharmaceutical compositions and a method of using same
US4680289A (en) * 1985-06-05 1987-07-14 Progenics, Inc. Treatment of obesity and diabetes using sapogenins
JPS62234025A (ja) 1986-04-03 1987-10-14 Asahi Chem Ind Co Ltd 老人性痴呆者用食品
US5017562A (en) * 1987-02-11 1991-05-21 Regents Of The University Of Minnesota Crystalline saponin-containing complex
DE3838716A1 (de) * 1988-11-15 1990-05-17 Kanoldt Arzneimittel Gmbh Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie
JPH02188528A (ja) 1989-01-13 1990-07-24 Tsurataka Tashiro 痴呆症治療薬
EP0515386B1 (en) * 1990-01-18 1999-12-22 Cura Nominees Pty Ltd Glycoalkaloids
SE9100342D0 (sv) 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
US5252729A (en) * 1991-10-23 1993-10-12 Schering Corporation Extraction of compounds from plant materials using supercritical fluids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
JPH05246866A (ja) * 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk 脳代謝促進・脳機能改善剤
BR9306619A (pt) * 1992-06-26 1998-12-08 Pfizer Glicosídeos esteroidais para o tratamento da hipercolesterolemia
DE4303214A1 (de) * 1993-02-04 1994-08-11 Wolfgang Marks Behandlung von Erkrankungen viraler, viroidaler oder onkogener Genese durch Steroid-Saponine oder deren Aglykone
AU6274394A (en) 1993-02-23 1994-09-14 Pharmakon Usa, Inc. Therapeutic herbal composition
CN1092992A (zh) 1993-03-29 1994-10-05 中国科学院沈阳应用生态研究所 提高脑功能的药物及其制备方法
CN1052636C (zh) 1993-03-29 2000-05-24 中国科学院沈阳应用生态研究所 文冠果子的醇提取物在制备治疗智力低下的药物中的应用
JPH06305952A (ja) 1993-04-27 1994-11-01 Sumitomo Pharmaceut Co Ltd スレオ−３−（３，４−ジヒドロキシフェニル）セリン経鼻投与製剤
BR9406332A (pt) * 1993-04-28 1995-12-26 Pfizer Mono-hidrato cristalino de espirostanil-glicosidal
CN1033754C (zh) * 1993-05-31 1997-01-08 上海第二医科大学 知母皂甙元作为制备β肾上腺素和M胆碱受体双向调节药的用途及其制法
CN1102186A (zh) 1993-10-29 1995-05-03 沈阳医学院 中药薤白新成分的鉴定及用途
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
EP0737202A1 (en) * 1993-12-28 1996-10-16 Pfizer Inc. Hypocholesterolemic agents
AU7948494A (en) * 1993-12-28 1995-07-17 Pfizer Inc. Steroidal glycosides
IL109614A (en) 1994-05-10 1998-06-15 Yissum Res Dev Co Comestible products containing saponins
US5563131A (en) 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5840740A (en) 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
SI9520092A (en) * 1994-08-30 1997-12-31 Pfizer Spirostanyl glycosidal crystals
EP0782451A1 (en) 1994-09-20 1997-07-09 Pfizer Inc. Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
JPH09100295A (ja) 1995-06-13 1997-04-15 Toray Ind Inc 新規トリテルペノイドサポニン類およびそれを有効成分とする神経突起伸展作用を有する治療剤
CU22860A1 (es) 1995-10-12 2003-05-26 Univ La Habana Espirostanonas con funciones oxigenadas en el anillo a. como reguladores del crecimiento vegetal y su procedimiento de obtención
US6130232A (en) 1995-10-13 2000-10-10 Banyu Pharmaceutical Coaltd Substituted piperidine derivatives as muscarinic M3 receptor antagonists
FR2743561B1 (fr) 1996-01-15 1998-02-20 Fournier Sca Lab Derives de steroides, procede de preparation et utilisation en therapeutique
KR0169536B1 (ko) 1996-02-27 1999-01-15 손경식 신규한 인삼 사포닌, 그의 제조방법 및 이를 유효성분으로 하는 항종양제
US5726179A (en) 1996-04-01 1998-03-10 The University Of Toledo Muscarinic agonists
US5962445A (en) 1996-05-09 1999-10-05 Amrad Operations Pty Ltd. Treatment of asthma and airway diseases
EP1506775A1 (en) 1996-07-22 2005-02-16 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders
US5804239A (en) * 1996-07-26 1998-09-08 Nouveau Technologies, Inc. Method and composition for food flavoring
WO1998051302A1 (en) 1997-05-15 1998-11-19 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
AU7980098A (en) 1997-06-20 1999-01-04 Elena Y. Enioutina Method to enhance innate immunity defense mechanisms by treatment with plan t-derived alkaloids
KR20010023208A (ko) 1997-08-28 2001-03-26 브루스, 제임스 에이취 허브 추출물의 화학 및 약리학적 표준화
JP3906948B2 (ja) * 1997-09-13 2007-04-18 本田技研工業株式会社 電動式変速装置の変速制御装置
CN1131237C (zh) * 1997-09-26 2003-12-17 中国人民解放军军事医学科学院放射医学研究所 甾体皂甙防治老年性痴呆的用途及新的甾体皂甙
CA2217088A1 (en) 1997-09-30 1999-03-30 Universite De Sherbrooke New mandevilla velutina derivatives as steady-state r-type ca2+ channel blockers, method of making and use thereof
JP3873097B2 (ja) * 1997-11-06 2007-01-24 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
GB9905275D0 (en) * 1999-03-08 1999-04-28 Phytopharm Ltd Treatment of conditions associated with membrane-bound receptors and their function
TR200002774T2 (tr) * 1998-03-26 2001-06-21 Phytopharm Plc Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
KR100292406B1 (ko) 1998-06-11 2001-07-12 윤종용 감광성중합체,용해억제제및이들을포함하는화학증폭형포토레지스트조성물
GB2347676A (en) 1999-03-08 2000-09-13 Phytopharm Plc Screening method
GB9923078D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
AUPP968699A0 (en) 1999-04-09 1999-05-06 Cura Nominees Pty Ltd Therapeutic compositions and method for their preparation
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
GB9923077D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
BR0001794A (pt) * 2000-05-15 2001-12-26 Laboratorios Biosintetica Ltda Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
US20050130948A1 (en) 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Also Published As

Publication number Publication date
AU778294B2 (en) 2004-11-25
HK1045525B (en) 2006-08-04
WO2001023406A1 (en) 2001-04-05
DK1224205T3 (da) 2006-06-12
EP1724279A2 (en) 2006-11-22
NZ518596A (en) 2004-07-30
PT1224205E (pt) 2006-08-31
CN101411712A (zh) 2009-04-22
CZ300150B6 (cs) 2009-02-25
HRP20020255A2 (en) 2003-08-31
US20060100184A9 (en) 2006-05-11
US7138427B2 (en) 2006-11-21
CA2640998A1 (en) 2001-04-05
IL180972A0 (en) 2007-07-04
NO20021541D0 (no) 2002-03-27
AU778294C (en) 2005-08-04
KR100771491B1 (ko) 2007-10-30
CA2385402C (en) 2009-01-13
DE60027913D1 (de) 2006-06-14
ZA200202382B (en) 2003-09-23
TR200200821T2 (tr) 2002-06-21
NO20021541L (no) 2002-05-28
MXPA02003305A (es) 2002-10-04
US20060276415A1 (en) 2006-12-07
CA2385402A1 (en) 2001-04-05
DE60027913T2 (de) 2007-01-11
PL357370A1 (en) 2004-07-26
CN100445295C (zh) 2008-12-24
NO324959B1 (no) 2008-01-14
RU2325396C2 (ru) 2008-05-27
ES2260055T3 (es) 2006-11-01
CY1105225T1 (el) 2010-03-03
US7507720B2 (en) 2009-03-24
AU7537500A (en) 2001-04-30
IL148920A0 (en) 2002-09-12
UA82978C2 (ru) 2008-06-10
EP1224205A1 (en) 2002-07-24
BR0014381A (pt) 2002-06-25
US20030004147A1 (en) 2003-01-02
JP2003510332A (ja) 2003-03-18
EP1224205B1 (en) 2006-05-10
GB9923076D0 (en) 1999-12-01
ATE325808T1 (de) 2006-06-15
HK1045525A1 (en) 2002-11-29
CN1377368A (zh) 2002-10-30
KR20020092914A (ko) 2002-12-12

Similar Documents

Publication Publication Date Title
HRP20080467A2 (hr) Derivati 5-beta-sapogenina i pseudosapogenina te njihova uporaba u liječenju demencije
BR0107691A (pt) Sapogeninas substituìdas e seu uso
AR033079A1 (es) Derivados de sapogeninas, sintesis y uso, y metodos en base a su uso
TR200002774T2 (tr) Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
NO20061736L (no) Krystallform av epotilon B
ATE358117T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
NO20000085D0 (no) Forbedrede metoder og sammensetninger for behandling av erektil dysfunksjon hos menn
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
GB9923078D0 (en) Sapogenin derivatives and their use
IL153540A0 (en) THE USE OF 7beta-HYDROXY-STEROID DERIVATIVES FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE60021632D1 (de) Verfahren zur gleichzeitigen Herstellung von Maleinsäureanhydrid und dessen hydrogenierten Derivaten
BR0015938A (pt) Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa
CY1105504T1 (el) Νεες συνθετες κρυσταλλικες δομες που περιεχουν φυτοστερολες και φυτοστανολες ή παραγωγα αυτων
MY134920A (en) 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
NO20030606L (no) Modifisert gj¶r og anvendelser derav, n¶rmere bestemt for fremstilling avsteroidderivater

Legal Events

Date Code Title Description
ODRP Renewal fee for the maintenance of a patent

Payment date: 20081022

Year of fee payment: 9

A1OB Publication of a patent application
OBST Application withdrawn